115 related articles for article (PubMed ID: 10695903)
1. Oxcarbazepine versus carbamazepine treatment and induction of serum lipid abnormalities.
Papacostas S
J Child Neurol; 2000 Feb; 15(2):138-40. PubMed ID: 10695903
[TBL] [Abstract][Full Text] [Related]
2. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
[TBL] [Abstract][Full Text] [Related]
3. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxcarbazepine.
Isojärvi JI; Pakarinen AJ; Rautio A; Pelkonen O; Myllylä VV
Epilepsia; 1994; 35(6):1217-20. PubMed ID: 7988514
[TBL] [Abstract][Full Text] [Related]
4. Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children.
Yilmaz E; Doşan Y; Gürgöze MK; Güngör S
Acta Neurol Belg; 2001 Dec; 101(4):217-20. PubMed ID: 11851028
[TBL] [Abstract][Full Text] [Related]
5. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K
Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483
[TBL] [Abstract][Full Text] [Related]
6. Effect of Carbamazepine and Valproate Monotherapy on Cardiovascular Risks in Epileptic Children.
Harit D; Aggarwal A; Kalra S; Chhillar N
Pediatr Neurol; 2015 Jul; 53(1):88-90. PubMed ID: 26092418
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants.
Verrotti A; Domizio S; Angelozzi B; Sabatino G; Morgese G; Chiarelli F
J Paediatr Child Health; 1997 Jun; 33(3):242-5. PubMed ID: 9259301
[TBL] [Abstract][Full Text] [Related]
8. Oxcarbazepine in glossopharyngeal neuralgia: clinical response and effect on serum lipids.
Luef G; Poewe W
Neurology; 2004 Dec; 63(12):2447-8. PubMed ID: 15623731
[No Abstract] [Full Text] [Related]
9. Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests.
Ley M; Principe A; Jiménez-Conde J; Rocamora R
Epilepsy Res; 2015 Sep; 115():147-52. PubMed ID: 26220393
[TBL] [Abstract][Full Text] [Related]
10. Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
D'Orazio JL
Clin Toxicol (Phila); 2008 Dec; 46(10):1093-4. PubMed ID: 18821094
[TBL] [Abstract][Full Text] [Related]
11. Central hypothyroidism with oxcarbazepine therapy.
Miller J; Carney P
Pediatr Neurol; 2006 Mar; 34(3):242-4. PubMed ID: 16504798
[TBL] [Abstract][Full Text] [Related]
12. Effect of carbamazepine therapy on serum lipids in children with partial epilepsy.
Aggarwal A; Singh V; Batra S; Faridi MM; Sharma S
Pediatr Neurol; 2009 Feb; 40(2):94-7. PubMed ID: 19135621
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of antiepileptic drugs on bone mineral density.
Babayigit A; Dirik E; Bober E; Cakmakci H
Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
[TBL] [Abstract][Full Text] [Related]
14. Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children.
Yiş U; Doğan M
Brain Dev; 2012 Mar; 34(3):185-8. PubMed ID: 21676567
[TBL] [Abstract][Full Text] [Related]
15. Effect of carbamazepine on serum lipids and liver function tests.
Aggarwal A; Kumar M; Faridi MM
Indian Pediatr; 2005 Sep; 42(9):913-8. PubMed ID: 16208051
[TBL] [Abstract][Full Text] [Related]
16. Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study.
Garoufi A; Koemtzidou E; Katsarou E; Dinopoulos A; Kalimeraki I; Fotinou A; Drakatos A; Attilakos A
Eur J Neurol; 2014; 21(1):118-23. PubMed ID: 24118208
[TBL] [Abstract][Full Text] [Related]
17. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
[TBL] [Abstract][Full Text] [Related]
18. Oxcarbazepine and hepatic porphyria.
Pierach CA
Epilepsia; 2002 Apr; 43(4):455; discussion 455. PubMed ID: 11952779
[No Abstract] [Full Text] [Related]
19. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
[TBL] [Abstract][Full Text] [Related]
20. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
